GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...
Patient organisations and charities are at risk of aligning their interests with their corporate funders even when this doesn't benefit their members, according to a new study led by the University of ...
But Dr. Robert Califf, who leads the government’s regulation of health software at the Food and Drug Administration, says his agency cannot monitor all advanced AI tools without a doubling of his ...